Impact of Field Selection in Nonmydriatic Retinal Imaging - PowerPoint PPT Presentation

1 / 18
About This Presentation
Title:

Impact of Field Selection in Nonmydriatic Retinal Imaging

Description:

Impact of Field Selection in Nonmydriatic Retinal Imaging for Diabetic Retinopathy in the Joslin Vision Network Lloyd M. Aiello, MD; Sharon Eagan, OD; Nigel Timothy ... – PowerPoint PPT presentation

Number of Views:72
Avg rating:3.0/5.0
Slides: 19
Provided by: mediaAmeri
Category:

less

Transcript and Presenter's Notes

Title: Impact of Field Selection in Nonmydriatic Retinal Imaging


1
Impact of Field Selection in Nonmydriatic Retinal
Imaging for Diabetic Retinopathy in the Joslin
Vision Network
  • Lloyd M. Aiello, MD Sharon Eagan, OD Nigel
    Timothy, MD Ann Tolson, BA
  • Kristen, Hock, BS Jerry Cavallerano, OD, PhD
  • Joslin Vision Network Team

2
Hypotheses
  • Single field nonmydriatic 45-degree JVN field
    (NM-1) will permit Category 1 and Category 2
    assessment of diabetic retinopathy (DR)
  • Single field nonmydriatic 45-degree JVN field
    (NM-1) will not permit Category 3 assessment of
    diabetic retinopathy compared with JVN protocol
    of three 45-degree stereoscopic fields (NM-1,
    NM-2, NM-3) and two 30-degree stereoscopic fields
    (optic disc centered and macula centered)

3
Background
4
ATA Position Statement Standards and Guidelines
in Telehealth for DR
  • Goals
  • Promote informed and reasonable patient and
    provider expectations
  • Address clinical, technical and administrative
    issues
  • ETDRS 30-degree seven-standard field color slides
    chosen as the standard for validating retinal
    images for DR telehealth

1.Telehealth Practice Recommendations for
Diabetic Retinopathy. Telemedicine Journal and
e-Health. 200410469-482.
5
Validation
  • Category 1 no (or minimal) DR vs. more than
    minimal DR.
  • Category 2 no sight-threatening DR vs.
    potentially sight-threatening DR present (severe
    or worse NPDR, any PDR, and DME)
  • Category 3 management to match clinical
    recommendations based on clinical retinal
    examination through dilated pupils
  • Category 4 can replace ETDRS photos in any
    clinical or research program

6
Joslin Vision Network
Screening
7
JVN Diabetes Eye Care
  • Validation JVN vs. 35 mm slides. Bursell S-E,
    Cavallerano JD, Cavallerano AA, Aiello LP, Aiello
    LM. Stereo nonmydriatic digital-video color
    retinal imaging compared with Early Treatment
    Diabetic Retinopathy Study seven standard field
    35-mm stereo color photos for determining level
    of diabetic retinopathy. Ophthalmology
    2001108572-585.
  • Validation JVN vs. clinical exam. Cavallerano
    AA, Cavallerano JD, Aiello LP, Aiello LM. Use of
    Joslin Vision Network digital-video nonmydriatic
    retinal imaging to assess diabetic retinopathy in
    a clinical program. Retina 2003 23215 223.
  • Validation JVN for annual f/u exam. Cavallerano
    J, Aiello LP, Cavallerano AA, Aiello LM. Joslin
    Vision Network Digital-Video Imaging as an
    Alternative for Subsequent Annual Retinal
    Examination in Persons with Previously Documented
    Mild Nonproliferative or No Diabetic Retinopathy.
    American Journal of Ophthalmology 2005
    140667-673.
  • Validation Nondiabetic eye disease. Chow SP,
    Cavallerano J, Hock K, Aiello LM, Aiello LP,
    Bursell S. Comparison of nonmydriatic digital
    retinal imaging with dilated clinical eye exam
    for detecting non-diabetes-related pathology in
    diabetic patients. Accepted for publication
    Ophthalmology 2006.

8
JVN FieldsRight Eye
9
Methods
  • N 233 patients (466 eyes)
  • Nonmydriatic retinal images per JVN protocol
  • Reader performs Category 1, Category 2, and
    Category 3 grading
  • 2nd masked reader performs Category 1 and
    Category 2 grading

10
Comparison
  • Category 3Joslin Vision Network
  • Determines clinical level of DR
  • Validated to clinical exam
  • Validated to 35mm ETDRS 7 standard field
    photography
  • Category 1DR present vs. no DR
  • Category 2 Sight-threatening DR vs. no
    sight-threatening DR
  • Any PDR or Macular Edema
  • Severe/Very Severe NPDR

11
Comparison of No Retinopathy and Ungradable
Studies by Category (n 466 eyes)
No sight-threatening diabetic retinopathy
12
Results
  • Category 117 eyes (13 patients) had DR not
    identified by Category 1 evaluation
  • Category 210 eyes (8 patients) had
    sight-threatening DR not identified by Category 2
    evaluation
  • Discrepancy due to lesions lying outside Category
    1 and Category 2 field

13
35-year-old male Type 1 DM-19 years Insulin
TID A1C 10.8
Field NM-1
14
Field NM-2
15
Field NM-3
16
33-year-old male Type 1 DM-23 years Insulin
TID A1C 9.5
Field NM-1
17
Field NM-2
18
Field NM-3
19
Discussion
  • Category 3 JVN protocol identifies more eyes with
    any DR (Category 1) and more eyes with
    sight-threatening DR (Category 2) as compared
    with single-field (NM-1)
  • This discrepancy in all cases was due to lesions
    lying outside Category 1 and Category 2 field
    (NM-1)
  • JVN protocol reduced the rate of ungradable
    studies

20
Summary and Conclusion
  • The JVN has been previously validated to identify
    level of diabetic retinopathy and diabetic
    macular edema
  • JVN single field (NM-1) alone does not allow the
    same degree of diagnosis of clinical level of DR
  • JVN field NM-1 has the potential to provide ATA
    Category 1 and Category 2 evaluations
  • Telemedicine programs for DR should clearly
    define patient and care provider expectations

21
Thank You
Write a Comment
User Comments (0)
About PowerShow.com